Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,065 signal articles · 235 in last 24h · 119,564 total before filter · latest 2h ago
235last 24h
1467last 7d
248● bullish (7d)
157● bearish (7d)
205publishers
AllMacro279Earnings562M&A105Regulatory20Product13Analyst22
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
IMAX Stock Crests Buy Point On Pre-Odyssey Earnings Surge
Investor's Business Daily27d agobullish
IMAX Stock Crests Buy Point On Pre-Odyssey Earnings Surge

IMAX stock projected an early entry buy signal on Thursday morning as a Q2 earnings beat added to momentum from its best-ever opening weekend. Christopher Nolan's "The Odyssey," the first-ever theatrical release shot in IMAX's largest and highest-resolution film format, delivered a record-breaking $52 million first-weekend haul for the immersive IMAX theaters alone. The blockbuster opening helped send AMC Entertainment past an early buy point on Monday but the liftoff for IMAX shares was postponed until after earnings.

RTX raises full-year outlook after strong second-quarter earnings (NYSE:RTX)
InvestorsHub27d agoneutral
RTX raises full-year outlook after strong second-quarter earnings (NYSE:RTX)

RTX (NYSE:RTX) shares surged nearly 6% in premarket trading on Thursday after the aerospace and defence company reported second-quarter earnings and revenue ahead of Wall Street expectations while increasing its financial guidance for the full year. The stronger outlook reflected robust demand across both its commercial aerospace and defence businesses, supported by a record order backlog.

Blackstone (NYSE:BX) Beats Expectations in Strong Q2 CY2026
StockStory27d agobullish
Blackstone (NYSE:BX) Beats Expectations in Strong Q2 CY2026

Alternative investment manager Blackstone (NYSE:BX) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 62.9% year on year to $5.04 billion. Its GAAP profit of $1.54 per share was 15.9% above analysts’ consensus estimates.

Cleveland-Cliffs shares jump as upbeat third-quarter forecast outweighs earnings miss (NYSE:CLF)
InvestorsHub27d agobullish
Cleveland-Cliffs shares jump as upbeat third-quarter forecast outweighs earnings miss (NYSE:CLF)

Cleveland-Cliffs (NYSE:CLF) shares climbed nearly 7% in premarket trading on Thursday after the steel producer issued a stronger-than-expected outlook for the third quarter, despite reporting a slight earnings miss for the second quarter. Investors focused on the company’s improving profitability and expectations for a significant increase in EBITDA during the current quarter.

Dow beats second-quarter expectations as pricing strength lifts earnings (NYSE:DOW)
InvestorsHub27d agobullish
Dow beats second-quarter expectations as pricing strength lifts earnings (NYSE:DOW)

Dow (NYSE:DOW) reported better-than-expected second-quarter earnings on Thursday, supported by higher selling prices across its business, particularly in polyethylene, helping offset a modest decline in sales volumes. The stronger results prompted a positive market reaction, with the company’s shares rising more than 2% in premarket trading.

T-Mobile shares decline despite earnings beat and higher cash flow forecast (NASDAQ:TMUS)
InvestorsHub27d agobullish
T-Mobile shares decline despite earnings beat and higher cash flow forecast (NASDAQ:TMUS)

T-Mobile (NASDAQ:TMUS) shares moved lower in premarket trading on Thursday after the wireless carrier reported second-quarter earnings above analysts’ expectations but fell short of revenue forecasts, despite lifting its full-year free cash flow outlook. While profitability and cash generation remained strong, investors focused on the slight revenue miss following another quarter of steady subscriber growth.

West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars
StockStory27d agobullish
West Pharmaceutical Services (NYSE:WST) Beats Expectations in Strong Q2 CY2026, Stock Soars

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.

Micron Stock Is Gaining After Google Earnings. Why SK Hynix Is Rising Even More.
Barrons.com27d agoneutral
Micron Stock Is Gaining After Google Earnings. Why SK Hynix Is Rising Even More.

Micron and SK Hynix stock were rising ahead of the open Thursday after earnings from Alphabet and signs of continued spending on memory helped ease fears that have hung over chip makers. SK Hynix was outdoing its U.S. rival, though the Korean memory giant has been susceptible to bigger swings recently, since it made its debut in the U.S. stock market earlier this month. Micron stock gained 3.5% in premarket trading on Thursday with SK Hynix’s American Depositary Receipts (ADRs) up 6.7%.